Safety Profile
Melanotan II Side Effects: Frequency & Severity
Melanotan II has a higher side effect burden than other peptides due to its non-selective melanocortin activity.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
Serious side effects
1Melanoma risk
Case reports of atypical melanomas in melanotan users. Causality not established but a serious concern.
Common side effects
7Nausea
Particularly in first doses; often severe.
Facial flushing
Melanocortin-mediated.
Loss of appetite
Can be substantial.
Skin darkening
Expected effect; generalized and/or patchy.
Moles/nevi changes
Existing moles may darken or enlarge; new moles may appear.
Spontaneous erections (male)
MC4R activation; can be prolonged.
Yawning
Melanocortin-related; distinctive side effect.
Uncommon side effects
2Dizziness
Transient.
Increased blood pressure
Transient.
Rare side effects
1Priapism
Prolonged erection; requires medical attention.
Contraindications
- Personal or family history of melanoma
- Numerous or atypical nevi
- Active malignancy
- Pregnancy and lactation
- Known hypersensitivity
Drug interactions
- PDE5 inhibitors — additive erection effects; increased priapism risk
- Alpha-blockers — unknown combined effect
Special populations
Not FDA approved. Not recommended in any special population. High safety concern profile.
Overall safety summary
Melanotan II has the highest concerning side effect profile on PeptideMark. Skin cancer concerns, priapism, and significant nausea are all substantial risks. PT-141 (bremelanotide) is a safer selective alternative for sexual function, and it is FDA approved.
Melanotan II side effects: FAQ
Can Melanotan II cause melanoma?
Case reports describe atypical melanomas in users. Causality has not been proven, but the theoretical mechanism (darkening and proliferation of pigmented lesions) is biologically plausible. Avoid if personal or family history of melanoma.